Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
about
Contrast Enhanced MRI in the Diagnosis of HCCNatural history of liver imaging reporting and data system category 4 nodules in MRI.Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.Identification of the collagen type 1 α 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinomaPrimary clear cell carcinoma in the liver: CT and MRI findings.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging featuresEctopic blood supply of hepatocellular carcinoma as depicted by angiography with computed tomography: associations with morphological features and therapeutic historyMRI features of hepatocellular carcinoma related to biologic behaviorDistinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRIComputer-aided diagnosis program for classifying the risk of hepatocellular carcinoma on MR images following liver imaging reporting and data system (LI-RADS).Synchronous multicentric small hepatocellular carcinomas: defining the capsule on high-frequency intraoperative ultrasonography with pathologic correlation.CT and MRI of hepatocellular carcinoma: an update.Imaging of HCC.Rare hepatic malignant tumors: dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature.Blood oxygen level-dependent liver MRI: can it predict microvascular invasion in HCC?Pathology-MRI Correlation of Hepatocarcinogenesis: Recent Update.Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma.Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.Effect of threshold growth as a major feature on LI-RADS categorization.Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy.Prostate cancer with a pseudocapsule at MR imaging: a marker of high grade and stage disease?Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI?Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.Hepatocarcinogenesis and LI-RADS.Complete tumor encapsulation on magnetic resonance imaging: a potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma.Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.Contrast-enhanced ultrasound of malignant liver lesions.Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging.Basic MRI for the liver oncologists and surgeons.Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA.LI-RADS v2017 for liver nodules: how we read and report.CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners.
P2860
Q26768472-B40CE4E4-6430-4E4D-BEF1-2166AA4A3601Q31090559-E20CE54D-7307-4621-8E37-FB9F86CD7323Q31108230-AA9CECF1-4615-44EB-B49C-2F904A189BB9Q33588150-1BDD017C-D78B-4006-B9A3-478A6428BD06Q34635076-FA70A74E-8C2F-467B-B053-F8AA63DAB7BDQ34681076-754EB29D-9A38-47F2-A0A6-A6CF1DA20222Q34682228-A5A92200-E84E-45B6-B007-371C278CFE6BQ34964729-3F36799D-0A65-44DF-878B-1DB9FD4EFBBEQ35619951-46657F90-2D62-4FB4-A8C6-B96A72C61E27Q35720896-180D9CE1-5E84-47FA-8B1C-41F289EBFE21Q36384510-18B44F59-9B16-4AA9-9425-CFCD24AF53F7Q37292309-F7DD11C2-7125-40B2-852A-39FBD751D7DEQ37732278-3B400EBF-EFB3-4381-9900-4F57E4ACA539Q37930465-75AA3F76-F3E4-467D-B345-BAA5FBB580E3Q38016333-ECFC3D22-0232-4658-B1F0-30D51AF606E4Q38057714-FEC53886-29EE-4B12-9300-AC6D156FBA96Q38505083-6BED3740-50CC-4CA9-9569-DBD4E02E56A0Q38587512-400DF6A7-A0D4-433C-9622-6DDC7E72E0BDQ38630810-17852F24-FD3A-4EB4-9E23-9F3669CC7292Q38684422-F412555A-9514-48A0-B50E-4128726B0CF8Q38869804-B5ABE4F8-97C4-4555-8F3B-B75F1AAC7EA7Q39259950-45DECFA6-4745-415D-BF3E-760EF5E81D36Q40707178-25EE4059-8AEE-4B74-81A6-A1D3C16EA48AQ40894274-DFB81FF5-588B-4B54-90B5-12E543388F28Q40989838-844E68A3-5F3F-4B6E-8504-262A10AAEB64Q42418559-DCDB1BAC-F280-4740-A3AC-4F53B8C09365Q43648361-99968A9F-AB52-487A-B0B1-90965942A3D1Q45972620-A25E3691-E9BA-4B5A-A3F2-65722BDC405EQ46073789-4A3DB461-463F-4915-A309-D2CB8C95B29DQ46170972-0B974F7C-C1A1-457E-A756-8E473855F34EQ47603110-F9BF7580-867D-4201-851F-165C958C4B26Q47730953-374D22FE-1ED2-4D4E-991C-216F0F13BFFEQ48378939-0F1CDE3C-7DB3-4E41-8FA6-AFB1F99B2D9BQ51816847-9BC1A1E6-43EF-46FB-9FB4-8FDC8D4C9141Q52310263-1BDF90D1-6541-4CC7-86CA-6CEFF61C4B76Q52927877-E5DC85E4-1D1E-4DCC-883C-1BB2FEB8DDF4Q52983889-2E28DD8F-27A3-49AE-ABD2-28E637EBBBA2Q53196060-7E125789-53DD-4E25-9057-E6DEB53C7075Q54964044-A06ACC66-9CF8-455C-B60E-4D5BE3A3187AQ55296234-CD9A98D0-A53E-4019-929F-81F985EEA53F
P2860
Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocellular carcinoma with ...... with histopathologic findings.
@en
Hepatocellular carcinoma with ...... with histopathologic findings.
@nl
type
label
Hepatocellular carcinoma with ...... with histopathologic findings.
@en
Hepatocellular carcinoma with ...... with histopathologic findings.
@nl
prefLabel
Hepatocellular carcinoma with ...... with histopathologic findings.
@en
Hepatocellular carcinoma with ...... with histopathologic findings.
@nl
P2093
P1433
P1476
Hepatocellular carcinoma with ...... with histopathologic findings.
@en
P2093
Akihiro Nishie
Akinobu Taketomi
Daisuke Okamoto
Hiroshi Honda
Hiroyuki Irie
Kengo Yoshimitsu
Kousei Ishigami
Masakazu Hirakawa
Tsuyoshi Tajima
Yasuhiro Ushijima
P304
P356
10.1148/RADIOL.2501071702
P407
P577
2008-12-18T00:00:00Z